Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

bioAffinity Technologies closes a $4M Private Placement Offering. This funding was priced at-the-market under Nasdaq rules.

PUBLIC · BIAFAug 14, 2026•about 21 hours ago

Amount Raised

$4 Million

Round Type

Seed

San AntonioBiotechnologyHealth CareTherapeuticsHealth Diagnostics

Description

bioAffinity Technologies has successfully closed a Private Placement Offering totaling $4 million. The offering was priced at-the-market in compliance with Nasdaq regulations. The funds will be used to support the company's growth initiatives. This move demonstrates the continued confidence of investors in bioAffinity's potential.

Company Information

Company

bioAffinity Technologies

Location

San Antonio, Texas, United States

About

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, and targeted cancer treatment. The Company’s first product, CyPath® Lung, is a non-invasive test that has shown high sensitivity and specificity for the detection of early-stage lung cancer. CyPath® Lung is marketed as a Laboratory Developed Test (LDT) by Precision Pathology Services. OncoSelect® Therapeutics, LLC, a subsidiary of bioAffinity Technologies, is advancing its discoveries shown in vitro to kill cancer cells without harm to normal cells. Research and optimization of the Company’s platform technologies are conducted in its laboratories at The University of Texas at San Antonio.

Don't miss bioAffinity Technologies's next move

Get an email the moment bioAffinity Technologies raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Verified contactsMaria Z., Chief Executive Officer, President and…
Predictive Intelligence
Strategic

ML-powered predictions for bioAffinity Technologies's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.